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Background: Percutaneous treatment of chronic total occlusion (CTO) has been increasingly adopted in recent years. However, longer-term 
vascular response has not been reported.
objectives: To investigate vascular response to sirolimus-eluting stent (SES) in CTO by optical coherence tomography.
methods: Fifty nine patients (21 patients/29 stents with CTO and 38/ 52 with non-CTO lesions) who underwent OCT imaging at 6 months after SES 
implantation were included in the analysis.
results: The CTO group, compared to the non-CTO group, had higher incidence of malapposition (27.6% vs. 7.7 %, p= 0.037), uncovered struts (> 
3 uncovered cross sections: 46.8% vs. 11.5%, p=0.0007), and protruding struts (71.8% vs. 44.2%, p=0.038).In-stent thrombus was detected in 3 of 
32 (9.3%) stents in CTO and 1 of 52 (1.9%) stents in non-CTO lesions (p=0.303). No adverse clinical event occurred in both groups.
conclusions: CTO lesions are associated with higher incidence of late stent malapposition and tissue protrusion, and lower neointimal coverage at 
6 months.
